International Journal of Infectious Diseases · 2017 · 45 citations · 20 references
Veterinary MedicineChild HealthInfectious DiseasesEpidemiologyImmunizationVaccinologyTropical MedicineVaccinationVaccination PolicyVaccine EffectivenessVaccine PolicyVaccine-preventable DiseasesDengue FeverDengue Hemorrhagic FeverDengue VaccinesEpidemiology Of Tropical DiseasesSeroconversion DetectionSeroconversion RatesSerological EpidemiologyTropical Infectious Diseases
BACKGROUND: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considering its introduction. METHODS: A community-based survey was conducted to estimate dengue seroprevalence and age-specific seroconversion rates in a community in Medellin, Colombia, using a dengue serological test (IgG indirect ELISA). Residents were selected at random and were first screened for dengue infection; they were then followed over 2.5 years. RESULTS: A total of 3684 individuals aged between 1 and 65 years participated in at least one survey. The overall dengue seroprevalence was 61%, and only 3.3% of seropositive subjects self-reported a past history of dengue. Among dengue virus (DENV)-naïve subjects with more than two visits (n=1002), the overall seroconversion rate was 8.7% (95% confidence interval 7.3-10.4) per 1000 person-months, over the study period. Overall, the mean age of DENV prevalent subjects was significantly higher than the mean age of seroconverted subjects. Specifically, DENV seropositivity over 70% was observed in participants over 21 years old. Serotype-specific plaque-reduction neutralization tests (PRNT) revealed that all four dengue serotypes were circulating, with DENV4 being most prevalent. CONCLUSIONS: These laboratory-based findings could inform dengue vaccine decisions, as they provide age-specific seroprevalence and seroconversion data, evidencing permanent and ongoing dengue transmission in the study area. This study provides evidence for the existing rates of secondary and heterotypic responses, presenting a challenge that must be addressed adequately by the new vaccine candidates.
20
Theo Vos, Amanuel Alemu Abajobir, Kalkidan Hassen Abate et al. · The Lancet · 2017 · 13.5K citations · Full text
The global distribution and burden of dengue
Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature · 2013 · 10.2K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +12
Jorge E. Osorio, Iván Darío Vélez, Cynthia A. Thomson et al. · The Lancet Infectious Diseases · 2014 · 151 citations · Full text